-

Barings Supports Strategic Acquisitions by Inverness Graham Investments’ Portfolio Company, Innovia Medical

CHARLOTTE, N.C.--(BUSINESS WIRE)--Barings, one of the world’s leading investment managers, announced today that it served as sole lender of senior secured credit facilities to support Inverness Graham Investments’ portfolio company, Innovia Medical, in its strategic acquisitions of Grace Medical and Hurricane Medical.

Headquartered in St. Paul, MN, Innovia Medical (“Innovia”) is a leading manufacturer of single-use surgical products and sterile processing systems for a broad range of surgical applications.

“Barings is thrilled to partner again with Inverness Graham, as we continue to be impressed by the firm’s ability to scale and enhance its portfolio companies,” said Scott Chappell, Managing Director in Barings’ Global Private Finance Group. “We believe the combination of Innovia Medical with Grace Medical and Hurricane Medical creates a highly compelling platform in the ENT and ophthalmic markets, and we look forward to supporting Inverness Graham as they continue to build on this momentum.”

“The additions of Grace Medical and Hurricane Medical represent a truly exciting milestone in Innovia’s journey and will be transformational to the growth of the combined business,” said Aliya Khaydarova, Managing Principal at Inverness Graham. “Grace Medical and Hurricane Medical meaningfully expand Innovia’s presence in the attractive ENT and ophthalmic markets, enhance the overall product portfolio and manufacturing capabilities, and unlock synergy opportunities with current and new customers. We look forward to supporting the combined team as they integrate and continue to drive accelerated growth.”

About Barings

Barings is a $470+ billion* global asset management firm that partners with institutional, insurance, and intermediary clients, and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual, seeks to deliver excess returns by leveraging its global scale and capabilities across public and private markets in fixed income, real assets and capital solutions.

*As at 30 September 2025

About Inverness Graham Investments

Inverness Graham is a Philadelphia based buyout firm focused on acquiring innovative, high-growth companies where technology is transforming traditional industry. The firm’s Flagship strategy focuses on businesses in Healthcare, Tech-Enabled Services / Software and Advanced Manufacturing. The firm’s Green Light strategy targets tech-enabled businesses where Environmental Sustainability is a key driver of accelerating growth. Inverness Graham executes a differentiated, repeatable model for value creation through its proprietary Strategic Platform Build approach. Founded by senior executives of the Graham Group, the firm builds upon a 60-year legacy of operational excellence, bringing substantial value creation resources and an innovative mindset to support its portfolio company partners.

Barings


Release Versions

More News From Barings

Barings Corporate Investors Announces Quarterly Cash Dividend of $0.40 Per Share

CHARLOTTE, N.C.--(BUSINESS WIRE)--The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the “Trust”) today announced that it has declared a quarterly dividend of $0.40 per share payable on January 16, 2026, to shareholders of record on December 30, 2025. Based on current projections through the end of 2025, the Trust expects the dividend will be comprised of net investment income. The final determination of the source and tax characteristics of this distribution will depend upon the...

Barings Participation Investors Announces Quarterly Cash Dividend of $0.37 Per Share

CHARLOTTE, N.C.--(BUSINESS WIRE)--The Board of Trustees of Barings Participation Investors (NYSE: MPV) (the “Trust”) today announced that it has declared a quarterly dividend of $0.37 per share payable on January 16, 2026, to shareholders of record on December 30, 2025. Based on current projections through the end of 2025, the Trust expects the dividend will be compromised of net investment income. The final determination of the source and tax characteristics of this distribution will depend up...

Barings Global Short Duration High Yield Fund Announces December 2025 Monthly Distribution of $0.1223 per Share

CHARLOTTE, N.C.--(BUSINESS WIRE)--The Barings Global Short Duration High Yield Fund (the “Fund”) (NYSE: BGH) announced its monthly dividend for December 2025 of $0.1223 per share, payable on January 2, 2026. Based on the Fund’s November 28, 2025 share price of $15.18 per share, the dividend represents an annualized yield of 9.67% per share. Based on current projections through the payable date, the Fund expects that this dividend will be comprised of net investment income. In addition, the Fund...
Back to Newsroom